Screening for subclinical rheumatic heart disease: addressing borderline disease in a real-world setting

Luke D Hunter1, Alfonso J K Pecoraro1, Anton F Doubell1

  • 1Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Academic Hospital, Francie van Zijl Drive, Tygerberg, 7505, Cape Town, South Africa.

Insights

Identifying inter-scallop separations (ISS) in mitral valve leaflets significantly reduces misclassification of rheumatic heart disease (RHD) in large-scale screening. This improves accuracy and efficiency for RHD detection programs.

Area of Science:

  • Cardiology
  • Echocardiography
  • Public Health

Background:

  • The World Heart Federation (WHF) criteria for rheumatic heart disease (RHD) create a large borderline category, hindering population-based screening.
  • Inter-scallop separations (ISS) of the posterior mitral valve leaflet, a normal variant, can cause mild mitral regurgitation (MR), leading to misclassification as borderline RHD.

Purpose of the Study:

  • To report findings from the Echo in Africa project, a large-scale RHD screening in South Africa.
  • To determine the proportion of borderline RHD cases that would be reclassified as normal with systematic identification of ISS-related MR.

Main Methods:

  • A prospective cross-sectional study screened 5255 students in underserved secondary schools using handheld ultrasound.
  • Abnormal handheld studies were followed by portable echocardiography.
  • Mechanistic evaluation was applied to isolated WHF 'pathological' MR cases to identify ISS-related MR.

Main Results:

  • 49 cases of definite RHD and 104 cases of borderline RHD were identified.
  • ISS-related MR was the cause in 70.5% of borderline RHD cases with isolated pathological MR.
  • Systematic identification of ISS-related MR markedly reduced the number of misclassified borderline RHD cases.

Conclusions:

  • Mechanistic evaluation identifying ISS-related MR significantly reduces misclassification in large-scale RHD screening.
  • Implementing ISS identification can decrease the cost and labor burden of RHD screening programs.
  • Accurate classification of RHD is crucial for effective public health interventions.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
49
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
29
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
36
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
33
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
18
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
32